ir.reunert.co.za

Reunert Limited Integrated Annual report 2013 | Home

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. CHIEF EXECUTIVE OFFICER'S REPORT.

http://ir.reunert.co.za/

OVERVIEW OF ir.reunert.co.za

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IR.REUNERT.CO.ZA

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.8 out of 5 with 4 reviews

5 star

1

4 star

1

3 star

2

2 star

0

1 star

0

Hey there! Start your review of ir.reunert.co.za

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.1 seconds

CONTACTS AT IR.REUNERT.CO.ZA

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

20

SSL

EXTERNAL LINKS

5

SITE IP

85.10.215.135

LOAD TIME

1.117 sec

SCORE

6.2

PAGE TITLE

Reunert Limited Integrated Annual report 2013 | Home | ir.reunert.co.za Reviews

<META> DESCRIPTION

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. CHIEF EXECUTIVE OFFICER'S REPORT.

<META> KEYWORDS

1 overview

2 about this report

3 code of ethics

4 who we are

5 our history

6 our businesses

7 where we operate

8 our key relationships

9 leadership review

10 chairman’s statement

CONTENT

Page content here

KEYWORDS ON PAGE

overview,about this report,code of ethics,who we are,our history,our businesses,where we operate,our key relationships,leadership review,chairman’s statement,ten year review,operational reviews,cbi electric,nashua,reutech,corporate governance,risk report

SERVER

Apache

POWERED BY

PHP/5.6.9-hetz1

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Reunert Limited Integrated Annual report 2013 | Home | ir.reunert.co.za Reviews

https://ir.reunert.co.za

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. CHIEF EXECUTIVE OFFICER'S REPORT.

INTERNAL PAGES

ir.reunert.co.za

1

Reunert Limited Integrated Annual report 2013 | Leadership review

http://ir.reunert.co.za/2013/leadership-review

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. Add / View notes.

2

Reunert Limited Integrated Annual report 2013 | Information communication technologies: Nashua

http://ir.reunert.co.za/2013/operational-reviews/nashua

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. Add / View notes. Rollout of produ...

3

Reunert Limited Integrated Annual report 2013 | Corporate governance

http://ir.reunert.co.za/2013/corporate-governance

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. Add / View notes.

4

Reunert Limited Integrated Annual report 2013 | Where we operate

http://ir.reunert.co.za/2013/overview/where-we-operate

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. Add / View notes.

5

Reunert Limited Integrated Annual report 2013 | Our businesses

http://ir.reunert.co.za/2013/overview/our-businesses

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. Add / View notes. Circuit breakers...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

OTHER SITES

ir.replicel.com

RepliCel | Using Cells for Healing

Tel: 604-248-8730 Toll Free: 1-800-248-5255. 4th largest cosmetics company worldwide. Ongoing tendon repair trial. Results expected in 2016. Ongoing skin rejuvenation trial. Results expected in 2016. Our stock trades on the OTCQB. And on the TSX Venture Exchange. TSXV: RP OTCQB: REPCF. Learn more about investing in RepliCel below. SIGN-UP HERE FOR FUTURE UPDATES. HERE’S WHAT INDUSTRY EXPERTS ARE SAYING:. 8220;When I can get potential blue-sky regenerative technologies like. Michael May, Centre for Commer...

ir.reprosrx.com

Repros Therapeutics Inc. - Investor Relations

Board of Directors and Management. Events, Presentations and Webcasts. Repros in the News. Events, Presentations and Webcasts. Repros in the News. 12:34 PM ET on Jan 12, 2017. Delayed at least 20 minutes. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Repros Therapeutics Inc.'s financial performance into perspective. Dec 19, 2016. Dec 12, 2016. View all releases ». 2408 Timberloch Place, B-7.

ir.resourcesconnection.com

Investor Relations - RGP

RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.

ir.resourcesglobal.com

Investor Relations - RGP

RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.

ir.retrophin.com

Retrophin, Inc. - Investor Relations

Retrophin, Inc. (NASDAQ: RTRX) is a publicly-traded, San Diego-based biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options. The Company is currently focused on several catastrophic diseases affecting children, including Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), and...

ir.reunert.co.za

Reunert Limited Integrated Annual report 2013 | Home

2013 ANNUAL INTEGRATED REPORT. How we create value. Material issues and risks. Board and executive management. Chief executive officer’s report. Chief financial officer’s report. Social, ethics and transformation report. Company secretary’s certification. Statements of comprehensive income. Notes to the cash flow statements. Statements of changes in equity. Notes to the annual financial statements. Principal subsidiaries Annexure A. Unconsolidated subsidiary Annexure B. CHIEF EXECUTIVE OFFICER'S REPORT.

ir.revamedical.com

Investor Relations | REVA Medical

Skip to main navigation. REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s lead product, the Fantom bioresorbable scaffold, received European CE Mark on April 3, 2017 for the treatment of coronary artery disease. ASX RVA.AX (CDI). Mar 30, 2018 12:26 AM EDT. 10 CDIs equivalent to one share of common stock. March 27, 2018. REVA Announces First Implant of Fantom Encore in Switzerland.

ir.rexenergycorp.com

INVESTOR RELATIONS | Rex Energy Corporation

Skip to main navigation. Owner and Leasing Relations. Feb 06, 2018. Rex Energy Announces Fourth Quarter and Full Year 2017 Production and Estimated Price Realizations and Provides Operational Update. Jan 23, 2018. Rex Energy Appoints New Chief Financial Officer. 7:18 PM EDT on Mar 29, 2018. Mar 14, 2018. Rex Energy Announces Sale of Non-Operated Oil and Gas Interests in Westmoreland, Centre and Clearfield Counties. Feb 06, 2018. Jan 23, 2018. Rex Energy Appoints New Chief Financial Officer.

ir.reynoldsamerican.com

Q4 Web Site Development

Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.

ir.rfot.pw

1.76精品地图补丁_传奇1.80装备补丁下载_热血传奇1.85装备补丁_传奇1.80合击

Http:/ www.zhjcfsb.com/cq/html498/ 1.80雷霆终极. 2009-2015 www.ir.rfot.pw.

ir.rgp.com

Investor Relations - RGP

RGP was founded in 1996 within a Big Four accounting firm. Today, we are a publicly traded company with 3,300 professionals, annually serving over 1,700 clients around the world from 68 practice offices. Headquartered in Irvine, California, RGP has served 87 of the Fortune 100 companies. July 16, 2015. Resources Global Professionals Q415 Earnings Conference Call. Resources Global Professionals Announces Quarterly Dividend Payment Date and New Stock Buyback Authorization. To Enhance Resident Safety.